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1. Introduction 
 
1.1 The Mouse as a Model Organism 
 
Model organisms are widely used in basic research to get insight into biological 
phenomena. Due to anatomic, physiologic and genetic similarity, the laboratory mouse 
(Mus musculus) is an excellent mammalian model for studying human gene function 
and regulation (van der Weyden et al., 2002). Also the short life cycle, the small size 
and the fully sequenced genome makes the mouse an attractive model system. 
Sequencing both, the mouse and the human genome showed that we share 99 % of our 
encoded sequences. The field of functional genomics is now interested in studying 
how these genes act and what pathways and processes they regulate in the 
physiological setting. (Nguyen and Xu, 2008) 
The first functional analyses in the mouse were limited to spontaneous mutations 
which occur in a very low frequency (~ 5 x 10-6 per locus) (Stanford et al., 2001). 
Therefore, several mutagenesis strategies have been developed through the last century 
trying to detect certain genes associated with interesting phenotypes. 
 
 
1.2 Mutagenesis Strategies 
 
1.2.1 Physical and Chemical Mutagenesis 
 
In the 1930s the first X-ray mutagenesis experiments were carried out. The interest 
increased when larger centres began to study the effects of radiation fall-out on genetic 
stability. Exposure to X-ray causes a mutation frequency which is 20 – 100 times 
higher than that of spontaneously occurring mutations (Stanford et al., 2001). 
However, the resulting mutations consist mainly of chromosomal aberrations which 
are not suitable for the analysis of single genes.  
Another mutagen that leads to such chromosomal rearrangements, especially smaller 
deletions and translocations, is the chemical chlorambucil. It shows a higher 
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mutagenesis frequency than X-ray. Both, X-ray and chlorambucil are useful for genetic 
screens and mapping studies but they do not lead to identification of individual gene 
function. Therefore, they are not used in high- throughput approaches. (Stanford et al., 
2001) 
A preferred approach to the mutagenesis strategies described above is chemical 
mutagenesis with the laboratory-synthesized mutagenic agent N-ethyl-N-nitrosourea 
(ENU). It is a highly effective compound to induce random, single base pair mutations 
(Kennedy and O'Bryan, 2006). ENU transfers its ethyl group directly to oxygen or 
nitrogen radicals in DNA, which results in mispairing leading to point mutations if not 
repaired (Justice et al., 1999). More than 82 % of sequenced mutations show AT to TA 
transversion and AT to GC transition. This preference for AT base pairs results in a 
higher mutation rate for AT-rich regions in contrast to GC-rich regions. Also the 
length of a gene affects the rate at which it will be mutated because larger genes 
provide a longer target for mutations. (Kennedy and O'Bryan, 2006) 
To create mutants, male mice are injected intraperitoneally with ENU resulting in 
random mutations in spermatogonial stem cells which can be passed on to the 
offspring (Kennedy and O'Bryan, 2006). Pre-meiotic spermatogonial stem cells show 
the highest rate of mutation of any cell type examined with a single locus mutation 
frequency of 6-1.5 x 10-3. In a single gene of choice the desired mutation is obtained in 
one out of every 175-655 screened gametes. (Justice et al., 1999)  
ENU can cause different mutated alleles of one gene (allelic series) which may have 
different effects on the protein product enabling the identification of the critical 
domains within a protein. Most of the induced mutations are loss-of function variants 
but also gain-of function mutants can be obtained. (Kennedy and O'Bryan, 2006) 
 
 
1.2.2 Generating Transgenic Mice 
 
Transgenic mice are genetically modified organisms which carry genome integrations 
of in vitro recombined DNA sequences and are able to inherit the mutation to the 
following generation (Rülicke, 2001). In mice there are different strategies known to 
produce transgenic founders. The first method to introduce foreign DNA into early 
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mouse embryos was retroviral infection (Jaenisch, 1976) followed by microinjection of 
DNA constructs into pronuclei of fertilized oocytes (Gordon et al., 1980). A later 
developed alternative is the introduction of foreign coding sequences into cultured 
embryonic stem (ES) cells followed by blastocyst injection of selected cells carrying a 
targeted mutation. The resulting chimeric animals can give rise to transgenic founder 
lines in the next generation (Carlson and Largaespada, 2005).  
There are many applications for transgenic animals. In basic research they are used to 
obtain information on gene function and regulation. Moreover, nowadays transgenic 
animals of several other mammalian species than mice are used to obtain high value 
products like recombinant proteins and xeno-organs for humans but also to improve 
animal products for human consumption (Houdebine, 2005).  
 
 
1.2.2.1 Viral Gene Transfer  
 
In 1976 the first transgenic mouse was produced by infection of 4-8 cell embryos with 
exogenous Moloney leukemia virus (MLV). The born chimeric animals were able to 
pass on the integrated virus DNA to their offspring (Jaenisch, 1976). However, the 
retrovirally delivered genes were frequently not expressed in the newborn mice 
probably due to recruitment of host factors which recognize viral long-terminal-repeats 
(LTRs) and repress viral gene expression (Pfeifer, 2004). This phenomenon of gene 
silencing has clearly reduced the utility of retroviral transgenesis. Another 
disadvantage of using retroviruses is their dependence on cell cycling. That means that 
gene transfer can only occur in host cells that are actively replicating at the time of 
infection (Pfeifer, 2004). 
The great breakthrough for viral transgenesis was the switch to lentiviruses. Lois et al. 
(2002) and Pfeifer et al. (2002) used HIV derived SIN vectors to transfer a transgene to 
murine preimplantation embryos at the zygote and morula stage, resulting in the 
generation of transgenic mice. For the first time satisfying transgene integration and 
expression could be demonstrated for the use of viral vector systems. Also germ line 
transmission could be shown. (Pfeifer, 2004) 
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Lentiviruses belong to the large family of retroviruses and are characterized by a 
complex genome and morphology. The best studied lentivirus is the human 
immunodeficiency virus (HIV). Like the simple retrovirus MLV, lentiviruses are 
enveloped viruses with a RNA genome carrying gag, pol and env genes, encoding for 
internal structure proteins, viral enzymes like reverse transcriptase and envelope 
glycoproteins. After infection of host cells, the viral RNA genome is reverse 
transcribed into DNA and gets integrated into the host genome where it serves as a 
template for the production of progeny virions. Lentiviruses carry at least three 
additional genes necessary for their more complex life cycle which allows them to also 
infect non dividing cells because of active transport of virus genome to the nucleus of 
host cells. (Pfeifer, 2004) 
When using viral vector systems for the generation of transgenic mice, the zona 
pellucida, a physical barrier that shields the embryo from viral infection has to be 
overcome. This can be performed either by removing the zona pellucida or by injection 
of viral particles into the space between zona pellucida and cell membrane of the 
zygote – the perivitelline space (Pfeifer, 2004). These techniques are less invasive for 
zygotes than the routinely used DNA pronuclear microinjection and, therefore, leading 
to an 8-fold increase in the number of transgenics per embryo treated and transferred to 
a surrogate mother. If just taking the offspring into account, lentiviral transgenesis is 
about 4-fold more efficient than pronuclear injection of recombinant DNA (Pfeifer, 
2004). Recent studies could show enhanced transgenesis by intracytoplasmic injection 
of envelope free lentiviruses into mouse zygotes, leading to a transgenic rate of 97 % 
with number of transgene insertions ranging from one to 32 (Yang et al., 2007). 
Yang et al. (2008) analysed lentiviral integration sites to determine if there are 
preferable sites for lentiviral integration in the early embryonic genome. They found 
no integration preference within specific chromosomes, repetitive elements or CpG 
islands but for integration into intragenic regions, especially in introns.  
Early generations of lentiviral vectors were able to produce functional vector particles 
up to a genome size of 16 kb, however, with low efficacy. It was found to increase the 
transgenic efficiency when using smaller vectors with genome sizes of 5-7 kb. When 
calculating the cloning capacity one has to include the backbone of lentiviral vectors 
necessary for appropriate infection which is genera
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1.2.2.2 Pronuclear Microinjection 
 
The possibility to introduce foreign DNA sequences into the one cell mouse embryo 
by microinjection has become a reliable and powerful method to study mammalian 
gene function. The male pronucleus is formed five to seven hours after fertilization, the 
female one is formed six to eight ours after entry of the sperm (Rülicke, 2001). 
Usually, a small volume containing 100 to 500 copies of the linear DNA-construct 
(Houdebine, 2005) is microinjected into the more-visible, male pronucleus (Stanford et 
al., 2001). Pronuclear injection can only be performed in mammals, because in lower 
vertebrates and invertebrates the pronuclei are not visible. Nevertheless, transgenesis is 
even possible in those species by DNA injection into the cytoplasm of the embryo 
(Houdebine, 2005).  
 
 
Figure 1: Mouse zygotes – pronuclear microinjection 
 
Development of pronuclei  A) Male and female pronucleus becomes visible. B) Injection of DNA into 
the male pronucleus. C) Pronuclei draw near each other. D) Pronuclei disappear before the first cell 
division. (Rülicke and Hübscher, 2000) 
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In some of the injected zygotes the exogenously added DNA that consists of a protein 
coding sequence and regulatory elements integrates randomly into the host genome 
and becomes a stably heritable genetic trait. The desired integration event occurs 
sometimes already in the zygote. Frequently observed integration events in later   
developmental stages results in mosaic founder animals (Brinster et al., 1985). Mostly,  
the foreign DNA is inserted at one integration site as a head-to-tail concatemere with 
up to hundred of copies, but also examples of multiple integration sites have been 
observed (Brinster et al., 1985; Woychik and Alagramam, 1998). Concatemerization of 
foreign DNA increases the possibility of chromosomal rearrangements, aberrant 
splicing, heterochromatin formation or gene silencing (Miskey et al., 2005).   
Integration into the host genome is just the first step. Once the transgene is integrated it 
should be expressed efficiently. A certain number of conditions have to be fulfilled to 
optimize transgene expression. Basically, the construct has to carry a promoter, splice 
sites, start- and stop-codon and a polyA-site. Long DNA fragments (100 kb or more) 
also contain further regulatory elements which are often located in a great distance 
from the transgene and its promoter. For correct RNA maturation and transfer of 
mature mRNA to the cytoplasm, the transgene should contain at least one intron. 
Additionally, the transgene must not contain too many GC-rich regions because they 
are often recognized as foreign elements and further their C becomes methylated 
(Houdebine, 2005). The successful expression of transgenes is also dependent on the 
integration locus. Heterochromatic regions consist of highly condensed DNA and are 
transcriptionally inactive. The transgene will not be expressed properly when 
integrated into heterochromatin or even in its nearness. This phenomenon is called 
“position effect variegation” (Rülicke, 2001).  
However, just 1-3 % of microinjected embryos become transgenic animals 
(Houdebine, 2005). This estimated frequency is based on losses during injection and 
prenatal lethality. In mice an average number of up to 25 % of born animals carry the 
transgene (Rülicke and Hübscher, 2000).  
Insertional mutations generated after pronuclear DNA injection are molecularly tagged 
by the transgene. This big advantage can be used to identify the integration locus by 
cloning of flanking regions. This fact enables insights to the genomic region disrupted 
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by the insertion and to identify endogenous genes that are possibly linked with the 
mutant phenotype (Woychik and Alagramam, 1998).  
 
 
1.2.2.3 Gene Targeting by Homologous Recombination 
 
The development of mouse embryonic stem (ES) cells in 1981 opened a new field of 
creating mouse mutants. It has become feasible to create mice carrying genetic 
alterations ranged from small point mutations and single gene disruption to large 
genomic deletions or even to generate specifically engineered chromosomal 
translocations (Muller, 1999). 
Embryonic stem cells are isolated from the inner cell mass of cultured pre-implanted 
blastocysts. Because of their pluripotency, they are able to differentiate into every 
single cell type of an individual including the germ cells, when reinjected into a host 
blastocyst. This capacity depends on the culture conditions that keep the cell in an 
undifferentiated state. The inhibition of differentiation can be obtained by feeder cells 
that additionally serve as a matrix for ES cell adherence and/or by adding leukemia 
inhibitory factor (LIF) to the culture medium (Muller, 1999). Injection of ES cells into 
a host blastocyst leads to the formation of a chimeric animal with somatic and germ 
cells emanated from both sorts of cells, the host inner cell mass cells and the injected 
ES cells. Through breeding one can obtain animals heterozygous for the genetic 
modification in every cell (Carlson and Largaespada, 2005).  
In 1986 it could be shown, that ES cells can be genetically modified in vitro by 
introduction of a transgene. Three years later the groups of Smithies and Capecchi had 
demonstrated, that recombination of incoming DNA and the homologous sequence 
present in the genome is possible (Babinet and Cohen-Tannoudji, 2001), even if this 
event is relatively rare compared to random integration which is 1000-fold more likely 
to occur (Vasquez et al., 2001). Recombination frequency is affected by many factors 
like length of total homology between vector and targeted locus or chromatin structure 
(Babinet and Cohen-Tannoudji, 2001). 
Homologous recombination of introduced DNA and the genome offers the possibility 
to create targeted mutants at a chosen locus. This method is widely used for creating 
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null mutants with at least one knocked out gene. For the creation of so called knock 
out mice two types of vectors can be used. (I) When using a replacement vector, one 
exon of an endogenous gene is disrupted by a neomycin resistance marker after 
homologous recombination with the linearized targeting vector. The vector is also 
flanked by a HSV thymidin kinase gene which gets lost upon homologous 
recombination but not upon random integration. (II) In contrast, insertion vectors are 
linearized within the region of homology between one exon and the marker gene that 
allows positive selection. Homologous recombination events lead to integration of 
vector sequences and partial duplication of genomic sequences. (Muller, 1999)  
Before the presumed phenotype of a knock out mutant can be analyzed, one must 
assess whether any residual protein is expressed by the targeted locus. As long as 
remaining coding sequences of the targeted gene are still present in the genome, 
truncated or mutant forms of the protein may still be expressed. Truncated 
polypeptides may acquire new properties like transdominant interactions with other 
proteins. (Muller, 1999) 
Removal of all coding sequences of a gene may circumvent this problem of residual 
protein expression. But deletion of large genomic regions can lead to loss of yet 
unknown genes resided in introns or encoded by the opposite strand, or regulatory 
elements controlling the expression of unrelated endogenous genes (Muller, 1999).  
An interesting variation of the targeting vectors for creating null mutants can be 
obtained by the so called “knock in” technology. This method uses the introduction of 
a given cDNA in frame with the coding sequence of the targeted gene. Homologous 
recombination between the vector and the endogenous gene results in expression of 
cDNA instead of the targeted gene. When using the coding sequence for a reporter 
gene like lacZ from E.coli, encoding β-galactosidase, the expression pattern of the 
targeted gene gets perfectly mimicked. This can be useful for studying expression 
patterns but also for monitoring the fate of cells that normally express the targeted 
gene. (Babinet and Cohen-Tannoudji, 2001) 
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1.2.2.4 Gene Trapping 
 
Gene trapping takes the middle path between random and target-oriented mutations. 
Trapping vectors are used to either disrupt transcription of chromosomal genes by 
random insertion or to report expression patterns of endogenous genes (Stanford et al., 
2001). There are several types of trapping vectors with different applications. On the 
one hand, trapping vectors are used to disrupt endogenous gene expression and, 
therefore, create null mutantions. On the other hand, special types of trapping vectors 
can be used to identify regulatory elements or to report expression patterns of 
endogenous genes (Stanford et al., 2001; Carlson and Largaespada, 2005). They are 
introduced into ES cells by electroporation or retroviral infection. Mutated cells are 
then selected and injected into blastocysts before they are transferred to pseudo 
pregnant foster mice (Nagy Andras et al., 2003).  
All three types of trapping vectors contain a reporter gene (e.g. lacZ) and a neomycin 
resistance gene driven by an autonomous promoter which allows selection in ES cell 
culture (Stanford et al., 2001). Promoter traps are the commonly used trapping vectors. 
They contain a splice acceptor followed by the reporter gene and a polyadenylation 
signal (pA site). The promoter trap vector needs to be inserted in the coding sequence 
of an endogenous gene for reporter gene expression. The resulting gene product is a 
fusion transcript and protein between the upstream sequence of the trapped gene and 
the reporter (Stanford et al., 2001; Carlson and Largaespada, 2005).  
The advantage of using promoter traps is that the insertion site is in transcribed DNA, 
so the disrupted gene can be identified by cloning. On the other side, the disadvantage 
of this strategy is the low integration frequency into exons (Stanford et al., 2001). 
In comparison, gene trap vectors contain a splice acceptor immediately upstream of the 
reporter gene and a polyadenylation signal. They are also lacking an own promoter. It 
will, like the promoter trap, also lead to a fusion gene product if integrated into an 
intron. This avoids the expression of the trapped gene but reports its expression 
pattern. Because insertion appears in an intron, alternative splicing can lead to a lower 
level of transcripts. (Stanford et al., 2001) 
Another useful trapping vector to identify regulatory elements of endogenous genes is 
the enhancer trap system. This type of vector includes a full expression cassette with a 
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minimal promoter which is not active unless affected by a positive cis regulatory 
element. (Carlson and Largaespada, 2005; Stanford et al., 2001) 
The drawback with the trapping vectors described above is that the reporter genes are 
not expressed when the trapped gene or promoter is not active in undifferentiated ES 
cells. To prevent this problem a so called polyA trap vector can be used. It contains a 
promoter, a reporter gene and a splice donor, but lacks a polyA signal. The reporter is 
expressed if inserted into an exon in the correct orientation. In this case the 
endogenous gene will also be disrupted. (Carlson and Largaespada, 2005) 
Trapping vectors are very useful tools to identify genes or regulatory elements and to 
study their gene function or expression patterns. 
 
 
1.2.2.5 Gene Targeting by RNAi: the Knock Down Approach 
 
Another valuable alternative for studying gene function in vivo is the RNA 
interference-based mutagenesis approach where expression of a chosen gene can be 
down regulated to a minimum. In 1998, Fire et al. described the phenomenon of post-
transcriptional gene repression by injection of double stranded (ds) RNA in adult C. 
elegans.  
RNA interference is a highly conserved mechanism throughout all kinds of organisms. 
When dsRNA is present in a cell, a complex cascade of molecular events gets started. 
During this pathway, the cellular enzyme Dicer binds to dsRNA and catalyzes the 
cleavage into short pieces of about 20 nucleotides in length known as small interfering 
RNAs (siRNAs). siRNAs are then incorporated in a RNA-induced silencing complex 
(RISC). This enzyme uses the incorporated siRNA to find and degrade the 
homologous mRNA. (Mocellin and Provenzano, 2004) 
RNA interference can be induced in mammalian cells either by transfection of dsRNA 
molecules or by expression of small hairpin RNAs (shRNAs). Both strategies will lead 
to Dicer catalyzed cleavage into siRNAs (Peng et al., 2006). 
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Figure 2: Schematic illustration of a small hairpin RNA construct 
promoter loop
shRNA
shRNA construct
 
ShRNA constructs consist of a promoter and a sense and antisense region separated by  
the loop sequence. Sense and antisense region are reverse complementary and form  
a hairpin structure through self pairing after transcription.  
 
For in vivo models, transgenic RNAi mice or rats can be produced either by ES cell 
manipulation, or directly by modification of the one-cell embryo by lentiviral infection 
or pronuclear injection of shRNA expression constructs. Upon genomic integration, 
the construct becomes stably inheritable and leads to long-term down-regulation of the 
chosen gene. (Peng et al., 2006) 
RNAi knock down technologies offer a lot of new possibilities especially for studying 
gene function in rats and other organisms where gene knock out is rather difficult 
compared to the well established ES cell based approach in mice.  
 
 
1.2.2.6 Gene Targeting by Zinc Finger Nucleases 
 
Zinc finger nucleases (ZNFs) are artificial restriction endonucleases which consist of 
two domains, a target site specific DNA binding domain fused to an unspecific 
nuclease domain. The binding domain is called zinc finger array and can be engineered 
to recognise any DNA sequence of interest. Once it binds to the target site, a double 
strand break is induced. Such a break can be repaired by non homologous DNA end 
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joining (NHEJ), an error-prone process which often leads to the creation of insertions 
or deletions at the site of the break. (Foley et al., 2009) 
ZFN induced DNA double strand breaks and the resulting non homologous end joining 
mediated repair can be used as a tool for highly efficient genome manipulations. They 
were already established for experiments in mammalian cell culture, in fruit flies and 
zebrafish and were recently used for the creation of knock out rats. (Foley et al., 2009; 
Geurts et al., 2009) 
For elimination of specific rat gene function, Geurts et al. (2009) delivered ZFNs to 
embryos by pronuclear or intracytoplasmic injection of either ZFN encoding DNA or 
mRNA. Best results were obtained by intracytoplasmic injection of high amounts of 
ZFN mRNA to disrupt IgM gene function. 75 % of born animals showed to carry 
mutations in the targeted genomic sequence but no gene disruption at any of 20 
predicted off-target sites indicating that ZFNs are highly specific for their target site.  
The strategy of ZFN-mediated genome manipulation opens up a range of new 
experiments especially in laboratory rats where targeted genome modifications are 
largely intractable. 
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1.3 Transposable Elements 
 
Transposable elements (TEs) are DNA sequences that possess an intrinsic capability to 
change their genomic position. In the 1940s Barbara McClintock first discovered 
chromosomal elements with the ability to move from place to place in maize (Comfort, 
2001). Nowadays, transposable elements have been detected in all organisms from 
bacteria to humans and form a major fraction of eukaryotic genomes (Miskey et al., 
2005). 35 % of the human genome is recognizable as transposon DNA compared to 
exons of cellular genes which represent about 5 % (Yoder et al., 1997). Nevertheless, 
most of these TEs are inactive because in the absence of selection pressure, “vertical 
inactivation” leads to accumulation of mutations in the transposon sequence (Ivics et 
al., 2004).  
TEs are distinguished whether their movement involves an RNA intermediate like 
retroelements (class I transposable elements) or relies exclusively on DNA 
intermediates like DNA transposons (class II transposable elements) (Miskey et al., 
2005).  
DNA transposons move in the host genome via a “cut and paste” mechanism. They are 
simply organized DNA sequences with a coding sequence for a protein called 
transposase flanked by inverted terminal repeats (ITRs) (Mates et al., 2007).  
Transpositon is catalyzed by the transposase which recognizes binding sites within the 
ITRs leading to excision and following reintegration (Miskey et al., 2005). 
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Figure 3: Schematic illustration – transposon excision and reintegration 
Transposase coding sequence5‘ ITR 3‘ ITR
Transposase coding sequence5‘ ITR 3‘ ITR
Transposase binds to ITRs
Synaptic complex for excision of transposon
New integration site
Genomic target site
 
Transposase binds to ITRs and catalyzes excision from genomic dondor site. Also following 
transposition and integration of transposon to genomic target site is catalyzed by the transposase. 
 
 
 
Transposition can easily be controlled by separating the source of transposase from the 
transposable DNA harbouring the ITRs, thereby creating a non-autonomous TE. In this 
case the transposon will only be able to move when the transposase is offered in trans 
(Mates et al., 2007).  
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Figure 4: Autonomous and non-autonomous TE 
+
Transposase
GOI Transposase
Autonomous TE
Non-autonomous TE
5‘ ITR 3‘ ITR
5‘ ITR 3‘ ITR
 
Non-autonomous TEs can be created easily by separating the transposase conding sequence from 
transposon DNA that harbours the ITRs. Every gene of interest (GOI) can be placed between the ITRs. 
 
 
The sequence between the ITRs plays no role for transposition. Any sequence of 
interest can be positioned between the ITRs, depending on experimental needs (Mates 
et al., 2007). Due to the ability to cause mutations by inserting into genes, transposable 
elements became a great tool for genetic manipulations, including the generation of 
transgenic animals and insertional mutants (Ding et al., 2005).  
 
 
1.3.1 Transposon-based Mutagenesis 
 
Since their discovery, TEs became invaluable tools for genetic analysis in many 
organisms. In prokaryotes, transposon-based mutagenesis has led to discovery of 
microbial pathogenesis genes. In eukaryotes, transposons have already been found to 
facilitate functional genetics research greatly in funghi, plants, lower metazoan models 
and invertebrates and have recently been established for their use in vertebrate genome 
manipulations (Ding et al., 2005; Mates et al., 2007; Miskey et al., 2005). 
Especially in Drosophila melanogaster transposons are widely used in many 
applications as important mutagenesis tools. The predominantly used transposable 
element in this species is the P element which is a currently active resident TE in 
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Drosophila. P elements are not active outside the Drosophila genus, indicating that 
host factors are required for transpositional events. Because they are present in recently 
wild caught strains but not in laboratory stocks established during the first half of the 
20th century, P elements are thought to be very recent invaders (Mates et al., 2007). 
This and also the high transpositional activity are the great advantages of this 
transposable element. In contrast to the Tc1 element used in Caenorhabditis elegans 
mutagenesis where mutation identification is very difficult because of multiple Tc1 
copies which are present in the genome, it was possible in laboratory Drosophila 
stocks to create transgenic flies each containing a separate component of the binary 
transposon system (Mates et al., 2007). One stock (“jump-starter”) was generated to 
carry the coding sequence for P element transposase, the other stock (“mutator”) was 
created to harbour a non-autonomous transposon in the genome. Upon inter-crossing, 
double transgenic flies are obtained. Through outcrossing to wild type animals the 
transposon can be mobilized and this leads to new integration sites. This system is 
extremely suitable for forward genetics applications and has also been tested for 
vertebrates like zebrafish (Ivics et al., 2004) and even for mice (Dupuy et al., 2001; 
Fischer et al., 2001; Ivics et al., 2004; Horie et al., 2001).  
Because of fairly inefficient homologous recombination in Drosophila, TEs can also 
be used here for reverse genetic approaches. For generating targeted gene replacement, 
TE excision induced double strand breaks resulting in DNA repair is used to enhance 
recombination frequency (Mates et al., 2007).   
When performing transposon-based mutagenesis, it is important to know the insertion 
patterns of different transposon systems. Chromatic integration patterns and tolerance 
for cargo size vary greatly between elements. While the efficiency of transposition 
exponentially decreases with increased cargo size of Tc1/mariner elements, for P 
elements the cargo size is not limiting utility (up to 100 kb are possible) (Mates et al., 
2007). Preference of integration sites should be checked before using a certain 
transposon system for mutagenesis purpose. Members of the Tc1/mariner family target 
their integration into TA dinucleotides and show no or weak preference for 
transcription units. The 5’ regulatory regions are disfavoured; most hits in genes are 
localized in introns. On the contrary, the P element shows a clear preference for 5’ 
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regulatory regions of genes. Also piggyBac which names an own transposon family, 
the piggyBac family, shows high preference for transcription units (Mates et al., 2007).  
Nowadays, several transposon systems are used for transgenesis and insertional 
mutagenesis in vertebrates, expanding our abilities in genome manipulations in 
vertebrate model organisms.  
 
 
1.3.2 Sleeping Beauty 
 
The best characterized DNA transposons found in vertebrates are members of the 
Tc1/mariner superfamily from teleost fish. Tc1/mariner elements are extremely 
widespread in nature, in contrast to other transposable elements like the P element 
(Drosophila) which is restricted to one genus. This indicates that host requirements for 
Tc1/mariner transposition are not that tight. All of the isolated TEs in vertebrates 
accumulated several mutations in their transposase genes and are therefore inactive 
(Ivics et al., 2004). In 1997, Ivics et al. engineered an active transposon system on the 
basis of a consensus sequence obtained from 12 remnant Tc1/mariner elements from 
eight different fish species and named it Sleeping Beauty (SB). 
The SB transposon system consists of two functional components: the transposase 
encoded by a synthetic gene, and a second, nonautonomous element carrying ITRs 
with recognition sites for the transposase. For transposition, both components have to 
at least temporarily co-exist in a cell (Ivics et al., 2004).  
Most transposable elements do not integrate randomly into the genome. Target 
selection can depend on DNA sequences or chromatin structure. SB shows a relatively 
random insertion profile. Transposition assays performed in human HeLa cells showed 
that although some chromosomes were hit more frequently than others, no clear 
preference for any chromosome could be detected. 35 % of the transposition events 
occurred in transcribed regions. About one third of the human genome is 
transcriptionally active, so this frequency suggests no preference for or against 
transcription units. (Ivics et al., 2004) 
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However, all Tc1/mariner elements, and so Sleeping Beauty, target their integration 
into TA dinucleotides. Upon integration the TA dinucleotide gets duplicated and flanks 
the newly inserted transposon (Mates et al., 2007). 
The activity of Sleeping Beauty transposase has been demonstrated in cultured 
mammalian cells, mouse embryonic stem cells, mouse hepatocytes, the one-cell mouse 
embryo and the mouse germline, declaring this transposon system as a useful tool for 
different approaches in vertebrate mutagenesis (Carlson et al., 2003). 
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1.4 Aim of the Study 
 
Mates et al. (2009) developed a hyperactive Sleeping Beauty transposase by 
incorporating phylogenetically conserved amino acids from related transposons 
belonging to the Tc1/mariner family into the SB transposase. Several variants were 
tested in a cell culture based transposition assay. Best results were obtained by an 
engineered transposase that showed 100-fold transposition activity as compared to the 
original SB transposase and was therefore named SB100X.  
To investigate the activity of SB100X in vivo, circular plasmids containing the reporter 
gene Venus (fluorescent protein) flanked by ITRs were coinjected with SB100X mRNA 
into the pronucleus of mouse zygotes. To determine the optimal concentration between 
the two injected components, embryos were cultured until day seven post injection and 
were then checked for fluorescence. The optimal injection solution was used for in 
vivo studies. 37 % of the born animals were transgenic and showed an average 
integration amount of one or two transgene copies per genome. 
 
In this study, the SB100X transposon system should be established for the routinely use 
in the production of transgenic mice. Therefore the in vitro optimized injection mix 
containing 0.4 ng/µl donor plasmid and 5 ng/µl SB100X mRNA should be used to 
generate a mutant mouse strain with the name B6;D2-Tn(Venus)Biat (short name: 
Venus-SB100X).  
The frequency of transgenic founders and the number of integrations per genome 
should be compared to the results from Lajos Mátès and his group at the Max 
Delbrück Center in Berlin. Furthermore, it should be cleared if all transgenic animals 
show expression of the reporter gene Venus which can easily be detected by 
fluorescence. An important part of the study is to show if the transgene is passed to the 
next generation and if silencing occurs. Additionally, it should be verified if 
integration events are truly catalyzed by the transposase to exclude cases of insertion 
by non homologous DNA end joining. 
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2. Material and Methods 
 
2.1 Material 
 
Equipment, chemicals, reagents and stocks, enzymes, kits, oligos and software used for 
the investigation are summarised in the appendix. Moreover, recipes for buffers and 
reagents are integrated there in detail.   
 
2.1.1 Animals 
 
Animals were free of all bacterial, viral, and parasitic pathogens listed in the 
Federation of European Laboratory Animal Science Associations recommendations 
and were maintained under specific pathogen-free conditions. Housing and 
experimental protocols were in accordance with the Austrian Animal Protection Law. 
For generation of transgenic mice super ovulated B6D2F1 females were mated with 
males of the same hybrid strain and used as donors to isolate zygotes for 
microinjection. CD1 females were used as surrogate mothers for transfer of 
manipulated zygotes. After genotyping of the resulting offspring, the transgenic 
founder animals were outcrossed with wild type mice of 129S5 origin. 
  
All animals were housed in the mouse facility at the Institute for Laboratory Animal 
Science and Biomodels Austria, University for Veterinary Medicine, Vienna. They 
were supplied with untreated tap water and breeding diet (SSNIFF Zuchtfutter V1126). 
Mice were held alone or in groups up to ten fully grown adults in Makrolon cages 
Type II or III filled with bedding type FS14 (Rettenmaier & Söhne). Cages were 
cleaned once a week. Sterile Pur-Zellin was provided as nesting material. From 6 – 18 
o’clock the rooms were lighted up with 200 lux in a height of two meters. Air was 
changed 8 times every hour. The humidity was between 30 % and 86 %, the 
temperature was fluctuating between 19.5 °C and 24 °C. 
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2.2 Methods 
 
2.2.1 Generation of Transgenic Mice 
 
Fertilized eggs from B6D2F1 mice were isolated and used for pronuclear 
microinjection of the circular vector pT2/Venus plus mRNA for SB100X transposase 
to generate the transgenic founders designated as B6;D2-Tn(Venus)Biat. The 
concentration of the injection solution was 0.4 ng/µl plasmid DNA and 5 ng/µl 
transposase mRNA. Treated zygotes were transferred to pseudo pregnant CD1 
recipients.  
 
The optimal concentration for injection mixes was tested before at the Max Delbrück 
Centre in Berlin Buch through ex vivo experiments. For that purpose, treated zygotes 
were cultured and checked for reporter gene expression at day seven post injection 
(Mates et al., 2009). 
 
Figure 5:  pT2/Venus plasmid map 
 
 
 
pT2/VENUS
6123 bp
TATA
TATA
(Extra SacII in this region)
CAGGS promoter
Amp CDS
SV40 PolyA
Ori
VENUS
5'ITR
3'ITR
PstI (4247)
XhoI (3534)
Nhe I (3520)
Sac II (5114)
Sal I (322)
BamHI (306)
BamHI (3212)
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2.2.2 Cloning of pT2/Venus 
 
For using SB100X transposon system for the routinely production of transgenic mice, 
the plasmid has to be cloned and stored. For later use, every sequence of interest can 
be cloned into the space between 5’ITR and 3’ITR. 
 
Chemically competent E.coli DH5α cells were transformed with the injection mix used 
for pronuclear microinjection (0.4 ng/µl pT2/Venus and 5 ng/µl SB100X transposase 
mRNA). The cells were put on ice for 30 minutes and then incubated at 42 °C for 45 
seconds. After heating, the cells were put on ice again for two minutes. After adding 
900 µl of SOC Medium cells were incubated on a shaker for one hour at 37 °C. 
Bacteria were plated on LB agar plates containing 50 µg ampicillin per ml agar for 
selection of plasmid carrying cells. Plates were incubated at 37 °C over night.  
 
One colony was picked and put in 3 ml liquid LB medium containing 150 µg 
ampicillin and incubated on a shaker for four hours at 37 °C. Then the cell solution 
was poured into 50 ml LB medium containing 2.5 mg ampicillin and shaked over night 
at 37 °C.  
 
Bacterial cells were centrifuged at 4 °C with maximum speed for 15 minutes. The 
supernatant was discarded; the pellet was stored at -20 °C. 
For reisolation of the amplified vector Plasmid DNA Purification (Midi Prep) for high-
copy plasmids (Machery Nagel, Düren, D) was performed like described in the user 
manual. 
 
The purified plasmid was digested with BglI to make sure that the correct plasmid was 
isolated. 
Number of fragments and their lengths after restriction digest was calculated by 
NEBcutter (New England BioLabs, Ipswich, UK). 
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Table 1: Reaction mix for BglI digest of isolated plasmid 
2 µg Plasmid DNA 
4 µl 10x buffer 
5 units BglI   
add ddH2O to a total volume of 40 µl  
37 °C for 2 hours 
 
80 °C for 20 minutes to inactivate the enzyme 
 
 
 
2.2.3 Analysis of Born Animals 
 
One to three day old mice were exposed to a lightsource (BLS, Budapest, H) with a 
wavelength of λ = 460-495 nm and checked for fluorescence. Only transgene positive 
mice with appropriate expression of reporter gene show yellow fluorescence.  
 
 
2.2.4 Sample Taking 
 
Three weeks old mice were marked by ear clip for identification. For tail biopsy 1 to 2 
mm tail tips were taken and stored at -20 °C.  
 
 
2.2.5 DNA Isolation 
 
2.2.5.1 DNA Isolation from Tail Samples (HOM) 
 
For “HOM” Isolation of DNA, tail samples were incubated over night at 60 °C with 3 
µl Proteinase K (20 mg/ml) and 500 µl HOM buffer. After vortex and 3 minutes of 
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centrifugation at 13200 rpm the supernatant was transferred to a new tube and 200 µl 
5M NaCl and 700 µl CIA (Chloroform:Isoamylalcohol 24:1) were added. After 10 
minutes of mixing by inverting, samples were centrifuged at 13200 rpm for 10 
minutes. The upper phase was carefully transferred to a new tube and charged with 1 
volume of isopropanol for DNA precipitation. Again it was mixed by inverting for 10 
minutes. After 10 minutes of centrifugation at 13200 rpm the supernatant was 
discarded and the pellet was washed once with 70 % (v/w) ethanol. The supernatant 
was removed and the pellet was air dried. 30 µl ddH2O were added to the pellet and 
incubated over night at room temperature for complete dissolving of DNA. DNA 
samples were stored at 4 °C or at -20 °C. 
 
 
2.2.5.2 DNA Extraction with PKII Buffer 
 
For diagnostic use only PKII extraction was performed. Tail tips were incubated for at 
least four hours or over night with 100 µl PKII buffer and 2 µl Proteinase K (20 
mg/ml) at 60 °C. To inactivate the Proteinase samples were cooked for 10 minutes at 
95 °C. After three minutes of centrifugation at 13200 rpm, 2 µl of the supernatant 
(from surface area) were directly used for PCR. This method leads to a poor purity of 
isolated DNA and lacks storage capabilities.  
 
 
2.2.6 Determination of DNA Concentration 
 
The concentration of dissolved DNA was analyzed with BioPhotometer by measuring 
the extinction (optical density, OD) at λ = 260 nm of a 1:25 dilution with ddH2O. For 
analysis a disposal cuvette with a path length of 10 mm was used. DNA concentration 
was calculated from the OD at λ = 260 nm, the dilution factor (d) and the dsDNA 
specific multiplication factor (f = 50) according to following formula: 
 
C [ng/µl] = OD260nm x d x f 
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Additionally the 260/280 nm ratio was determined to check protein contamination of 
the samples. The dynamic range is between 0.1 and 2 OD. 
 
 
2.2.7 Degradation Check by Agarose Gel Electrophoresis 
 
To make sure that genomic DNA is in good conditions and not degraded it was 
analyzed via agarose gel electrophoresis. Therefore 2 µl of isolated DNA were diluted 
with 8 µl ddH2O and charged with 1 µl 10x loading dye. The whole sample was 
loaded on a 1 % agarose gel containing 0.05 µg/ml ethidium bromide. Electrophoresis 
was performed for 30 minutes to 1 hour with 5 V/cm in 0.5 % Tris/borate/EDTA 
(TBE). DNA was visualized with Gel iX Imager. 
As a length marker GeneRulerTM DNA ladder mix was loaded. 
 
Figure 6: Visualizing genomic DNA 
42-50,52,53
 
Genomic DNA from Venus-SB100X animals with the numbers 42-50, 52 and 53 was loaded to see if 
DNA is degraded. Degraded DNA would be visible as a long smear in the whole lane. Non-degraded 
DNA runs very high in the 1% agarose gel and does not show a smear.  
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2.2.8 PCR Diagnostics 
 
2.2.8.1 Genotyping PCR 
 
For detection of Venus positive mice, genomic DNA was analyzed via touchdown 
PCR. Therefore primers were used to amplify a 501 bp fragment from the Venus 
coding sequence.  
As an endogenous control primers were used to amplify a 678 bp fragment from the 
Collagen14a1 gene. 
 
Primer sequences: 
Venus fw   5’-ACCTACGGCAAGCTGACCCTGAA-3’ 
Venus rev   5’-CTGGTAGCTCAGGTAGTGGTTGT-3’ 
 
WT 1F   5’-GGGGAAATGTCACCTTCAAA-3’ 
WT 1R  5’-TGGTTGAGGATGGCTGTGTA-3’ 
 
 
Figure 7: Schematic illustration of the transposon fragment 
Venus coding sequenceCAGGS promoter right ITRleft ITR
Venus fw Venus rev
 
This fragment gets integrated into the mouse genome during transposase-mediated excision from the 
pT2/Venus plasmid and integration into the genome. Venus fw and Venus rev are primers which bind 
within the Venus coding sequence. 
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Figure 8: Schematic illustration of exon 47 and intron 46 of the gene Collagen14 
Col14a1 intron 46Col14a1 exon 47
WT 1FWT 1R
 
WT 1R binds within exon 47 of the Collagen14 gene, WT 1F binds to intron 46 resulting in a 678 bp 
fragment in the PCR reaction. 
 
 
Table 2: Reaction mix for genotyping PCR 
µl/reaction  stocks 
   
0.5 Venus fw 10 µM 
0.5 Venus rev 10 µM 
0.5 WT 1F 10 µM 
0.5 WT 1R 10 µM 
2 dNTPs 2 mM each 
2 PCR buffer 10x 
2 MgCl2 15 mM 
0.1 Taq Polymerase 5 units/µl 
2 genomic DNA  
9.9 ddH2O  
 
 
 
 
 
 
 28 
Table 3: PCR conditions 
 1 min 94 °C 
 45 sec 92 °C 
6 cycles  -1 °C/cycle 1 min 61-55 °C 
 3 min 72 °C 
 45 sec 92 °C 
26 cycles 1 min 54 °C 
 2 min 72 °C 
 
 
PCR products were diluted with 10x loading buffer. 10µl were loaded on a 2 % 
agarose gel containing ethidium bromide for visualizing. 
 
 
2.2.8.2 Backbone-Specific PCR 
 
To certain that only the transposon got integrated and not the whole plasmid, primers 
were used which bind within the ampicillin resistance cassette present on the vector 
pT2/Venus and lead to a 854 bp amplicon in the PCR.  
 
Primer sequences: 
Amp long fw 5’-ATGAGTATTCAACATTTCCGTGTC-3’ 
Amp long rev 5’-TGCTTAATCAGTGAGGCACCTA-3’ 
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Table 4: Reaction mix for backbone specific PCR 
µl/reaction  stocks 
   
0.2 Amp long fw 10 µM 
0.2 Amp long rev 10 µM 
2 dNTPs 2 mM each 
2 PCR buffer 10x 
2.6 MgCl2 15 mM 
0.1 Taq Polymerase 5 units/µl 
2 genomic DNA  
10.9 ddH2O  
 
 
Table 5: PCR conditions 
 4 min 95 °C 
40 cycles 30 sec 95 °C 
 30 sec 63 °C 
 30 sec 72 °C 
 7 min 72 °C 
 
PCR products were diluted with 10x loading buffer. 10 µl were loaded on a 1 % 
agarose gel for visualizing. 
 
 
2.2.8.3 PCR for the Detection of SB100X Coding Sequence 
 
To detect if the injected SB100X mRNA got transcribed into DNA and integrated to 
the host genome, PCR was performed. Therefore, primers that bind within the SB100X 
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coding sequence were used. In the PCR, a fragment with a length of 576 bp was 
amplified.  
 
Primer sequences: 
SB100X fw  5’-TCAGCAAGGAAGAAGCCACT-3’ 
SB100X rev 5’-TTCCTCCTGACAGAGCTGGT-3’ 
 
 
Table 6: Reaction mix for SB100X-PCR 
µl/reaction  stocks 
   
0.5 SB100X fw 10 µM 
0.5 SB100X rev 10 µM 
2 dNTPs 2 mM each 
2 PCR buffer 10x 
2 MgCl2 15 mM 
0.1 Taq Polymerase 5 units/µl 
2 genomic DNA  
10.9 ddH2O  
 
 
Table 7: PCR conditions for SB100X-PCR 
 5 min 95 °C 
35 cycles 30 sec 95 °C 
 40 sec 65 °C 
 40 sec 72 °C 
 7 min 72 °C 
 
PCR products were analysed by agarose gel electrophoresis. 
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2.2.9 Histology 
 
Cerebrum, cerebellum, myocardium, skeletal muscle, pancreas, stomach, liver, spleen, 
kidney, testis, epididymis and lung were fixed in 4 % phosphate-buffered formalin for 
24 hours at room temperature. Following embedding was performed over night by an 
automatic embedding equipment system Shandon Excelsior Tissue Processor (Thermo 
Fisher Scientific, USA). Solvents and times were according to the following protocol: 
 
1. Ethanol 75 % (v/w)  30 °C 60 minutes 
2. Ethanol 80 % (v/w)  30 °C 60 minutes 
3. Ethanol 96 % (v/w)  30 °C 60 minutes 
4. Ethanol 96 % (v/w)  30 °C 60 minutes 
5. Ethanol 100 % (v/w)  30 °C 60 minutes 
6. Ethanol 100 % (v/w)  30 °C 60 minutes 
7. Xylen  30 °C 40 minutes 
8. Xylen  30 °C 40 minutes 
9. Xylen  30 °C 40 minutes 
10. Paraffin (Histo-Comp) 61 °C 80 minutes 
11. Paraffin  61 °C 80 minutes 
12. Paraffin  61 °C 80 minutes 
 
Sections of 3 µm were made and put on coated slides. 
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2.2.9.1 Staining of Sections 
 
The samples were stained with DAPI according to following protocol: 
 
1. Xylen 2 minutes 
2. Xylen 2 minutes 
3. Ethanol 100 % (v/w) 1 minutes 
4. Ethanol 100 % (v/w) 1 minutes 
5. Ethanol 96 % (v/w) 1 minutes 
6. Ethanol 70 % (v/w) 1 minutes 
7. Aqua dest. 1 minutes 
8. PBS 1 minutes 
9. DAPI 3 minutes 
10. washing 3 times for 20 seconds with PBS 
11. mounting with Mowiol (Hoechst, Frankfurt) 
 
Stained sections were examined with a confocal laser scanning microscope (Zeiss).  
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2.2.10 Dephosphorylation of GeneRulerTM DNA ladder mix 
 
For later labeling of 5’ termini of the GeneRulerTM DNA ladder mix with 32Phosphor, 
the 5’ phosphate had to be removed. 
 
 
Table 8: Reaction to remove 5’ phosphate from GeneRulerTMDNA ladder mix 
1 µl DNA ladder mix (0.5 µg/µl) 
2.5 µl 10x buffer 
2 µl Calf Intestine Alkaline Phosphatase (1 
unit/µl) 
19.5 µl ddH2O 
37 °C for 1 hour 
 
85 °C for 15 minutes to inactivate the enzyme 
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2.2.11 Labelling the 5’ termini of DNA with 32Phosphor 
 
Table 9: Reaction to label GeneRulerTMDNA ladder mix 
5 µl GeneRulerTMDNA ladder from 
phosphatase reaction 
33 µl ddH2O 
96 °C for 5 minutes to denature possible secondary structures 
then put on ice 
5 µl 10x PNK buffer A 
5 µl γ32P ATP 
2 µl PNK (10 units/µl) 
37 °C for 1 hour 
 
70 °C for 12 minutes to inactivate the enzyme 
 
Table 10: Reaction to label the primer Tbal 
1 µl Tbal (50 µM) 
37 µl ddH2O 
96 °C for 5 minutes to denature possible secondary structures 
then put on ice 
 
5 µl 10x PNK buffer A 
5 µl γ32P ATP 
2 µl PNK (10 units/µl) 
37 °C for 1 hour 
 
70 °C for 12 minutes to inactivate the enzyme 
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2.2.12 Transposon Display 
 
To determine the number of transposon integrations in the genome of Venus-SB100X 
founder animals, Transposon Display was performed with 12 randomly selected 
founder animals. 
 
 
Figure 9: Schematic illustration of Transposon Display 
Restriciton digest with FspBI
Linker ligation
Nested PCR
 
In the first step genomic DNA is digested with FspBI. Linker sequences are ligated to every fragment. 
Nested PCR is performed with primers binding within the linker region and transposon specific primers. 
The transposon specific primer for the second PCR is 32P labelled to make only specific products visible. 
 
 
In the first step 300 ng of genomic DNA were digested with FspBI (BfaI). This 
restriction enzyme cuts at the palindromic sequence: 5’-C^TAG-3’ 
        3’-GAT^C-5’ 
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Within the integrated transposon sequence, there is a FspBI restriction site 299 bp next 
to the beginning of the left ITR.  
 
Table 11: Restriction digest of genomic DNA 
300 ng genomic DNA 
2 µl 10x buffer 
5 units FspBI   
add ddH2O to a total volume of 20 µl  
37 °C for 2-3 hours 
 
65 °C for 20 minutes to inactivate the enzyme 
 
 
After restriction digest, a linker sequence was ligated on both sides of every fragment. 
To generate this linker, two complement oligos were annealed. 
 
Oligo sequences: 
BfaI linker (+) 5’-GTAATACGACTCACTATAGGGCTCCGCTTAAGGGAC-3’ 
BfaI linker (-)  5’-TAGTCCCTTAAGCGGAG-3’ (5’ phospho, 3’ amino) 
 
The 3’ amino modification of BfaI linker (-) is necessary to avoid polymerase-
mediated elongation in later PCRs. 
 
For the annealing of the linker, oligos BfaI linker (+) and BfaI linker (-) were mixed to 
a final concentration of 10 pmol/µl each in TE buffer containing 50 mM NaCl. Slow 
annealing was performed in the PCR machine. 
 
94 °C       2 minutes 
80 °C       5 minutes 
75 °C     10 minutes 
70 °C     10 minutes 
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65 °C     10 minutes 
60 °C     10 minutes 
55 °C     10 minutes 
50 °C     10 minutes 
45 °C     10 minutes 
37 °C     10 minutes 
 
Table 12: Reaction for linker ligation 
10 µl (150 ng)  FspBI digested genomic DNA 
2 µl annealed linker (10 pmol/µl) 
5 µl T4 Ligase buffer 10x 
6 units T4 Ligase  
add ddH2O to a total volume of 50 µl  
16 °C over night 
 
65 °C for 10 min to inactivate the enzyme 
 
 
Nested PCR was performed using primers which bind to a sequence within the linker 
(Linker Primer, Nested Primer) and primers which bind to the transposon sequence 
(Tbal rev3, Tbal). 
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Table 13: Reaction mix for the first PCR 
µl/reaction  stocks 
   
1.5  ligated DNA  
5 PCR buffer 10x 
5 MgCl2 15 mM 
5 dNTPs 2 mM each 
1 Linker Primer 10 µM 
1 Tbal rev3 10 µM 
0.5 Taq Polymerase 5 units/µl 
31 ddH2O  
 
 
Table 14: PCR conditions 
 2 min 96 °C 
 40 sec 92 °C 
5 cycles  -1 °C/cycle 40 sec 68-63 °C 
 1 min 72 °C 
 40 sec 92 °C 
10 cycles  -0.5 °C/cycle 40 sec 63-58 °C 
 1 min 72 °C 
 40 sec 92 °C 
20 cycles 40 sec 57 °C 
 1 min 72 °C 
 10 min 72 °C 
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10 µl of the PCR product were mixed with 10x loading buffer and loaded on a 1 % 
agarose gel to see if the PCR worked. 
 
For further use the PCR product was diluted 1:100 with ddH2O and stored at -20 °C. 
 
Table 15: Reaction mix for the second PCR 
µl/reaction  stocks 
   
1 100x diluted first PCR product  
5 PCR buffer 10x 
5 MgCl2 15 mM 
5 dNTPs 2 mM each 
1 Nested Primer 10 µM 
1 Tbal (32P labeled) ~ 1 µM 
0.5 Taq Polymerase 5 units/µl 
31.5 ddH2O  
 
 
Table 16: PCR conditions 
 2 min 96 °C 
 40 sec 92 °C 
10 cycles  -1 °C/cycle 40 sec 66-56 °C 
 1 min 72 °C 
 40 sec 92 °C 
10 cycles 40 sec 56 °C 
 1 min 72 °C 
 10 min 72 °C 
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To visualize the second PCR product, a denaturing 4 % polyacrylamid gel was 
prepared: 
 
 22.7 ml H2O 
 22.5 g Urea 
 5 ml TBE 10x 
 5 ml Polyacrylamid 40 % (19:1) 
 400 µl APS 10 % 
20 µl TEMED 
 
Before loading the samples, the gel pre ran for 1 hour at 200 Volt in 1x TBE. Slots had 
to be rinsed out with buffer directly before the samples were loaded. 
50 µl of 2x formamide loading buffer were added to the reaction of the second PCR. 
After 4 minutes of incubation at 95 °C samples were put on ice and loaded directly 
from ice. 10 µl were loaded on the gel.  
GeneRulerTMDNA ladder mix from the labelling reaction was diluted 1:5 with water 
and charged with 2x formamide loading buffer. 5 µl were loaded on the gel.  
The gel ran for about 2 hours at 250 Volt and was afterwards dried on a 3 MM 
Wattman Paper under vacuum and 80 °C.  
The dried gel was exposed to an X-ray film. After 4-7 days the film could be 
developed. 
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3. Results 
 
3.1. Cloning the Transposon Carrying Vector pT2/Venus 
 
Plasmid DNA can occur in three conformations, which should all be detectable by 
agarose gel electrophoresis after isolation from bacterial cells. To check isolated 
pT2/Venus DNA after amplification in E.coli and reisolation, 1 µg of plasmid was 
loaded on a 1 % agarose gel.  
Supercoiled plasmid DNA runs faster in the gel than linearized plasmids and plasmids 
with single strand breaks. 
 
When the undigested plasmid had been loaded, all three conformations could be 
detected. Most of the plasmid DNA is linearized which could have happened during 
dissolving the precipitated plasmid with too much vortexing. 
 
Figure 10: Three conformations of undigested plasmid DNA 
single strand break
linearized plasmid
supercoiled plasmid
 
1 µg of undigested pT2/Venus DNA was analysed by agarose gel electrophoresis.  
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BglI digest was made to make sure that the isolated plasmid shows the expected 
pattern of fragment lengths. First, pT2/Venus sequence was digested in silico using the 
online programme NEBcutter (New England Biolabs). In Figure 11 detailed 
information about coordinates of restriction sites is given and the predicted pattern of 
fragment lengths in a 0.8 % agarose gel after a real digest is shown. 
 
Figure 11: Expected results for BglI digested pT2/Venus DNA 
715843-5913BglI-BglI5
1225914-6035BglI-BglI4
12671758-3024BglI-BglI3
18456036-1757BglI-BglI2
28183025-5842BglI-BglI1
Length (bp)CoordinatesEnds#
 
NEBcutter from New England BioLabs was used to show the pattern of digested pT2/Venus DNA in a 
0.8 % agarose gel and coordinates of restriction sites on the plasmid. 
 
 
When loading BglI digested pT2/Venus DNA on a 1 % agarose gel (like in Fig), only 
the three large fragments were visible. To detect the small fragments with 122 bp and 
71 bp, a higher amount of plasmid DNA (at least 10 µg) had to be digested and ran on 
a 2 % agarose gel with high speed (1.5 times higher Voltage than usual). 
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Figure 12: pT2/Venus after BglI digest 
A B
 
A) 10µg of pT2/Venus has been digested and was loaded on a  
2 % agarose gel with high speed to make the smaller fragments (122 and 71 bp)  
visible. Picture B shows the three larger fragments in a 1 % agarose gel after  
BglI digest of pT2/Venus. 
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3.2 Generation and Analysis of Transgenic Mice 
 
All together 157 treated zygotes were implanted into pseudo pregnant CD1 foster 
mothers after microinjection of circular plasmid pT2/Venus and SB100X mRNA. 
After three weeks of pregnancy 61 mice were born which means that 38.8 % of 
implanted zygotes evolved into living animals.  
8 animals died within the first three days. 53 remaining mice were marked by ear clip 
when they were three weeks old and tail tips for DNA isolation could be taken. 
 
 
3.2.1 Macroscopical Fluorescence Analysis 
 
Newborn mice were checked for fluorescence. 37 out of 61 animals showed overall 
fluorescence, one animal showed signs of mosaicism.  
These numbers lead to a rate of 62.3 % out of newborn animals that showed reporter 
gene expression. 
4 fluorescent animals died within their first days.  
 
 
Figure 13: Fluorescent and non-fluorescent siblings 
A B
 
A) Under normal light conditions no fluorescence emission is visible. B) Animals were exposed to a 
light source (BLS, Budapest, H) with a wavelength of λ = 460-495 nm to detect expression of the 
fluorescent protein Venus in one animal. 
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3.2.2 Genotyping PCR  
 
PCR with transgene specific primers was performed to detect transgene carrying 
animals. In Venus positive animals a 501 bp amplicon could be detected. The 
amplicon from the Collagen14 gene used as an endogenous control is 678 bp long.  
All animals (53) that survived until day 21, when tail tips for DNA isolation could be 
taken, were tested and 34 (64 %) of them were positive for the Venus coding sequence. 
All genotypic confirmed founder animals correspond with the animals that showed 
fluorescence which means that no transgene silencing took place in the founder 
animals.  
  
 
Figure 14: Detection of Venus positive mice 
34-53
+  - -
1   2  3   4   5   6   7   8   9  10  11 12 13 14 15 16 17 18 19 20 21 22 23 24 25
500 bp
1000 bp
 
In lane 1 and 25 DNA ladder was loaded. PCR products from samples of Venus-SB100X animals 34 to 
53 were loaded in lanes 5 to 24. The positive control is in lane 2, two non-template controls are in lane 3 
and 4. Animals number 34 and 51 don’t carry the Venus coding sequence.  
 
 
3.2.3 Backbone-Specific PCR 
 
To make sure that integration into the mouse genome was transposase mediated, 
backbone specific PCR was performed. If the whole injected plasmid had been 
integrated via the cell machinery, it could be detected with the primers Amp long fw 
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and Amp long rev which bind within the ampicillin resistance gene present on the 
pT2/Venus vector. During PCR a 854 bp fragment gets amplified. 
All Venus-SB100X animals (number 1-53) were tested. The ampicillin resistance gene 
was not found in any of these animals. 
 
 
Figure 15: Detection of vector integration 
1   2   3                                                       25
854 bp
DNA ladder was loaded in lane 1 and 25. The pT2/Venus plasmid was used as a positive control, the 
PCR product was loaded in lane 2. In lane 3 a non-template-control was loaded. PCR products from the 
Venus-SB100X animals with the numbers 34 to 53 were loaded in lanes 5 to 24. None of these loaded 
samples carries the ampicillin resistance gene.  
 
 
3.2.4 SB100X-PCR 
 
SB100X-PCR was performed to detect genomic integrations of the coding sequence 
for the SB100X transposase. Such integration events could have occurred after possible 
transcription of mRNA into DNA. This process is comparable to the formation of 
pseudo genes where endogenous genes get duplicated during retrotransposition which 
includes an RNA intermediate.  
SB100X fw and SB100X rev are primers that bind within the coding region for 
SB100X and lead to amplification of a 576 bp fragment in the PCR. 
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Venus-SB100X founder animals were tested but none of them gave a positive result in 
the PCR. 
 
 
Figure 16: Detection of SB100X integration by PCR 
+  - 1  2  4  6  13 14 15 16  19 20 21 23 26 28 29 30 35 36
37 38 39 40 41 42  43 44 45 46 47 48 49 50 52 53
 
All Venus-SB100X founder animals were analysed via SB100X-PCR for genomic integrations of 
SB100X coding sequence. None of them gave a positive signal in the PCR. 
 
 
3.2.5 Histology 
 
To show that reporter gene expression takes place in every organ a Venus-SB100X 
animal from the F1 generation which showed overall fluorescence as a newborn has 
been analyzed via histology. 
When the abdomen had been opened, all the inner organs except the spleen showed 
strong fluorescence.  
 
Histology of 12 different organs showed that the fluorescent protein Venus is 
expressed in every organ but not in every cell within an organ. In some cells the 
protein seems to be located in either the nucleus or the cytoplasm, in other cells it was 
found in both.  
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Figure 17: Fluorescent abdomen of a Venus-SB100X animal 
skeletal muscle
liver
spleenintestine
 
The opened abdomen has been macroscopically checked for fluorescence. Except  
for the spleen, the whole abdomen shows fluorescence.  
 
Figure 18: Sections of 12 organs from a Venus-SB100X mouse 
cerebrum cerebellum myocardium skeletal muscel
pancreas stomach liver spleen
kidney testis epididymis lung
 
Venus expression could be detected in sections of all 12 analysed organs including the spleen. Nuclei 
were stained with DAPI.  
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3.2.6 Inheritance Analysis 
 
To find out if the transgene is passed to the next generation and if silencing occurs 
during germline passage, every founder was mated with a 129S5 wild type animal. 
The number of transgene carrying animals in the F1 generation additionally gives the 
possibility to demonstrate if the transgenic founder is either a genetic mosaic or carries  
more than one independent integration sites of the transgene.  
A non-mosaic animal which carries just one transgene integration site should 
statistically pass it onto 50 % of its progeny when mated to wild type. More than 50 % 
of transgenic mice in the F1 generation would mean that the transgenic mother/father 
carries more than one transgene copy.  
F1 animals were checked for fluorescence and were analyzed via genotyping PCR. 
Within all F1 animals two non-fluorescent mice were determined as transgenics via 
genotyping PCR, pointing out that gene silencing can happen with transposon 
mediated transgenes.  
 
Table 17: Results from inheritance analysis 
number/name of 
founder animal n progeny 
n fluorescent animals 
among progeny 
n transgenics among 
progeny (%) 
    
1 9 5 5 (56) 
2 10 7 7 (70) 
4 16 4 4 (25) 
6 14 3 3 (21) 
13 8 3 3 (38) 
14 9 8 8 (89) 
15 9 8 8 (89) 
16 9 9 9 (100) 
19 7 6 6 (86) 
20 9 8 8 (89) 
21 8 3 3 (38) 
23 7 3 3 (43) 
26 8 4 4 (50) 
28 6 3 3 (50) 
29 9 3 3 (33) 
30 8 5 5 (62) 
35 4 3 3 (75) 
36 3 3 3 (100) 
37 12 12 12 (100) 
38 7 5 5 (71) 
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39 8 8 8 (100) 
40 9 7 7 (78) 
41 5 4 4 (80) 
42 22 22 22 (100) 
43 4 1 1 (25) 
44 8 7 7 (88) 
45 15 1 1 (7) 
46 5 5 5 (100) 
47 8 8 8 (100) 
48 6 4 5 (83) 
49 12 6 6 (50) 
50 10 9 10 (100) 
52 6 1 1 (17) 
53 7 5 5 (71) 
 
 
One third of founder animals had 50 % or less of transgenic pups within their litters. 
Two third had 50-100 % transgenic progeny.  
 
When more than 50 % of animals within a litter showed fluorescence, intensity was 
often uneven (Figure 19). On the opposite, the intensity between siblings was 
comparable, when 50 % or less of the litter showed fluorescence.  
 
 
Figure 19: Offspring of founder Nr.37 
 
Litter of founder Nr. 37 with 12 pups were checked for fluorescence one day after birth. Every single 
animal in this litter shows fluorescence but intensities are uneven. 
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3.2.7 Transposon Display 
 
For determination of transgene integration numbers via Transposon Display, 6 female 
and 6 male founder animals were randomly selected. 
 
pT2/Venus was used as a positive control. The expected fragment after the second 
PCR should be 742 bp long.  
 
After the first PCR, products were analysed on a 1 % agarose gel containing ethidium 
bromide before they were diluted 1:100 for the second PCR. 
During the first PCR step a lot of unspecific products accumulate. This happens 
because of the Linker primer who binds to all the linker sequences which were ligated 
to every genomic fragment on both sides. 
 
 
Figure 20: Visualizing the first PCR product on an agarose gel 
+    - 1     6   20  21  26  30  37  41   42  44  49  50  52 
 
GeneRulerTMDNA ladder mix has been used as a lenght marker. 10 µl of the first  
PCR products were loaded on a 1 % agarose gel.  
 
In the second PCR, a 32P labelled, transgene specific primer (Tbal), was used to make 
only transgene specific products visible. Products were analysed via polyacrylamid gel 
electrophoresis. The gel was dried on a 3MM Wattmanpaper and exposed to an X-ray 
film where radioactive PCR products become visible as black dots.  
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As a comparison, the second PCR was also performed with non-labelled Tbal and 
products were loaded on a 1 % agarose gel.  
 
 
Figure 21: Visualizing the second PCR product on an agarose gel 
+   - 1   6  20 21 26  30 37 41 42 44  49 50 52
 
GeneRulerTMDNA ladder mix has been used as a length marker. Samples from  
the second PCR were loaded on a 1 % agarose gel. Animal number 6 does not  
show a specific band in this picture. 
 
 
In the second PCR the unspecific products get still amplified (visible as a smear in 
figure 21) but transgene specific products dominate and are visible as clear bands on 
the agarose gel.  
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Figure 22: Detection of transgene copy numbers by Transposon Display 
+    - 1     6   20  21  26  30  37   41  42   44   49   50  52 
500 bp
1000 bp
400 bp
300 bp
200 bp
 
The polyacrylamid gel was dried after electrophoresis and exposed to an X-ray film. 32P labelled PCR 
products from nested PCR are visible. Labelled GeneRulerTMDNA ladder mix was used as a length 
marker and has been loaded in the first and the last lane. Animals with only one transgene integration in 
their genome give one signal on the film. Several signals per sample would mean that the analysed 
animal carries more than one transgene integration. In this picture animal number 6 shows no signal.  
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Table 18: Analysed founder animals and number of transgene integrations 
Number/name 
of founder 
Transgene 
integrations 
Transgenic 
offspring in % 
 
    
1 one 56  
20 several 89  
21 one 38  
26 one 50  
30 several 62  ♀ 
37 several 100  ♂ 
41 several 80  
42 several 100  
44 one or two 88  
49 several 50  
50 several 100  
52 one 17  
 
 
One third of analyzed animals showed to carry only one copy of the transgene. Two 
third showed multiple integrations from 2 copies per genome up to possible 7 copies.  
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4. Discussion 
 
Transgenic model organisms are important tools to study gene function and regulation. 
Especially the mouse became an important mammalian model organism.  
The commonly used method to generate transgenic mice is microinjection of 
recombinant DNA into the pronucleus of fertilized oocytes. Treated zygotes are then 
transferred to a pseudo pregnant foster mother. 
This method leads to a rate of up to 25 % transgenic founders out of born animals 
(Rülicke and Hübscher, 2000). Usually, the injected linear DNA is integrated into the 
murine genome by the cell machinery as a head-to-tail concatemere with up to hundred 
of copies (Brinster et al., 1985). This phenomenon can lead to diverse types of 
chromosomal rearrangements, abberant splicing or gene silencing by heterochromatin 
formation (Miskey et al., 2005). 
Attractive new tools for transgenic technologies are so called cut-and-paste 
transposons. They are simply organized DNA sequenced with inverted terminal repeats 
(ITRs) flanking the coding sequence for the transposase which is necessary for 
excision of transposon sequence and reintegration to a target site (Miskey et al., 2005; 
Mates et al., 2007). When the source for the transposase is separated from the ITR 
carrying sequence, the created two component system can be easily used for insertional 
mutagenesis. For integration of transposon sequence to the genome, the two 
components have to at least temporarily coexist in the cell (Mates et al., 2007). 
Depending on the research purpose there are many tranpsoson systems which can be 
used for transgenesis and insertional mutagenesis. The activity of Sleeping Beauty, a 
member of the best characterized transposon superfamily, the Tc1/mariner family, has 
been demonstrated in several approaches for vertebrate mutagenesis. Even more 
attractive for mouse transgenesis is a hyperactive Sleeping Beauty transposase 
(SB100X) that has been developed at the Max Delbrück Centre in Berlin. This mutated 
transposase was a 100 times more active in cell culture experiments than the original 
enzyme. First in vivo experiments showed that SB100X can be used to produce 
transgenic mice by pronuclear microinjection of a donor plasmid carrying a gene of 
interest flanked by ITRs and SB100X mRNA. In a first attempt 37 % of born animals 
were transgenic and showed one or two transgene integrations. (Mates et al., 2009) 
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With the use of a circular plasmid instead of the normally used linear fragments, host 
factor mediated integration can be reduced to a minimum. When transgene integration 
occurs it is very likely that integration is catalyzed by the transposase.  
The transposase could also be provided by an expression plasmid, but transcription in 
the one-cell mouse embryo is limited, therefore mRNA was used to guarantee proper 
expression.  
In this study, a comprehensive analysis of SB100X transgenic mice should be made to 
clearify the way for the routinely use of this hyperactive transposon system for the 
production of transgenic mouse models. 
Injection experiments with the in vitro optimized ratio between donor plasmid and 
transposase mRNA have been performed at the Institute for Laboratory Animal 
Science, University for Veterinary Medicine, Vienna. Briefly, 62.3 % of born animals 
were transgenic and all of them showed expression of the transgene Venus which could 
easily be detected by fluorescence. Only one animal showed signs of mosaicism as a 
baby but due to lacking tagging possibilities it was not possible to seek this animal out 
later. Dissection and histological analysis of possible candidates would give us more 
information about the mosaic but transgenic founder animals are still used for breeding 
studies.  
Transposase-mediated transgene integration has been verified by PCR where primers 
were used to detect the ampicillin resistance gene present on the backbone of the 
injected vector pT2/Venus. A positive signal would have meant that either the 
backbone alone got integrated by the cell machinery after excision of the transposon or 
that the whole vector (backbone + transposon) got integrated after injection. None of 
the transgenic animals showed to carry the ampicillin resistance gene indicating that 
every integration event was catalyzed by the transposase. These results are not 
astonishing when we think about the small amount of plasmid DNA that had been 
injected. 0.4 ng/µl is very low compared to the commonly used concentration of 2 
ng/µl of linear DNA in an injection buffer used for pronuclear microinjection. Maybe 
the likeliness for vector integration increases when a higher amount of plasmid DNA is 
injected.  
Additionally, we analysed if the injected transposase mRNA got transcribed into DNA 
and integrated into the genome afterwards. This very unlikely process is comparable to 
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the formation of pseudo genes which are present in eukaryotic genomes and accrue by 
retrotransposition of endogenous genes (Thibaud-Nissen et al., 2009). The coding 
sequence for SB100X was not found in any of the genomes of our founder animals. If 
the transposase would have been provided by an expression plasmid, genomic 
integrations would have been more likely. This is another reason why the use of 
mRNA as a transposase source should be preferred over expression plasmids.  
Histology was performed to check transgene expression in several organs and to detect 
differences in fluorescence intensities within these organs. All analysed organs showed 
trangene expression but not every cell within an organ was fluorescent. Sometimes the 
fluorescent protein was located in the nucleus, sometimes in the cytoplasm and 
sometimes in both. Comparison of animals with different transgene integration sites 
would be interesting and would possibly show if expression patterns differ with the 
integration locus, a phenomenon known as position effect variegation.  
Very important parts of this project were inheritance analysis. All 34 founder animals 
were mated with 129S5 wild type animals. Analysis of progeny gives information 
about silencing events and about the number of transgene integrations in the genome of 
the founder mother/father. Only two out of nearly 300 tested F1 animals were 
determined as transgenic via PCR but did not show transgene expression. Breeding 
studies with these animals would be interesting to see if transgene expression can be 
reactivated in the following generations.  
Comparison of breeding results and results from Transposon Display, where number of 
trangene integrations were determined, showed that animals with one copy of the 
transgene had 50 % or less of transgenic pups within their litters. Animals with several 
transgene copies had 50 to 100 % of transgenic pups. An interesting fact was that 
fluorescence intensities were not even within litters where all the pups showed 
fluorescence. This phenomenon can have two reasons. Either the intensity of 
fluorescence correlates with the number of transgene copies or with the integration 
locus or with both.  
Both methods, matings and Transposon Display, led to the cognition that one third of 
founder animals carry only one copy of the transgene, the others showed several 
integration sites with a varying number of two to possibly seven independent 
integrations. The disadvantage of Transposon Display is that you can not be a 100 % 
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sure that the bands you see on the X-ray film are all specific. An animal which gives 
only one signal on the X-ray film carries only one integration but it is not possible to 
distinguish between unspecific and specific signals when an animal shows for example 
five signals on the film. Therefore, it was important to verify the results from the 
Transposon Display with those from the breeding studies. For establishing a transgenic 
line the founder animal has to carry one stable genomic integration. More than one 
integration would mean that independent segregation is very likely and progeny will be 
genetically unequal. Unfortunately, the majority of our created founder animals carries 
more than one transgene copy which can be explained by the high activity of SB100X. 
Using a lower amount of transposase for microinjection would possibly reduce the 
number of multiple integration events.  
Hyperactivity of SB100X makes this transposase a very attractive tool for the 
production of transgenic mice by pronulear microinjection. The very high transgenic 
rate of 62.3 % that could be reached and the possibility to create mutants with single 
transgene integrations instead of concatemeres are big advantages of using transposons 
for mouse mutagenesis.  
Still uncleared questions are cargo size capacity and chromatic integration patterns for 
SB100X. The original Sleeping Beauty transposase shows decreasing efficiency with 
increasing cargo size. In transposition assays performed in HeLa cells, no preference 
for or against transcription units could be detected (Ivics et al., 2004). Before SB100X 
is routinely used for mouse transgenesis it should be cleared if the hyperactive derivate 
shows similar characteristics as the original Sleeping Beauty transposase concerning 
these questions. 
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6.2 Summary 
 
Transgenic mouse models became indispensable tools for studying gene function and 
regulation. Pronuclear microinjection of in vitro recombinant DNA is the commonly 
used method to create mutants with stably inheritable genomic integrations of 
introduced DNA sequences.  
DNA transposons came to the focus of researchers mainly through their use in 
Drosophila genetics but have also been proved of value for mutagenesis approaches in 
prokaryotes or lower metazoans and have been established recently for their use in 
vertebrate genome manipulations. In this study, the newly developed hyperactive 
transposase SB100X was used to create transgenic mice with transposase mediated 
stable genomic integrations of a reporter gene. A donor plasmid containing the reporter 
gene coding sequence flanked by inverted repeats (cognition sites for the transposase) 
was co-injected in the pronucleus of a one-cell mouse embryo with the SB100X mRNA 
which should catalyze excision of transposon from the plasmid and integration to the 
murine genome. Manipulated embryos were carried to term by a pseudopregnant 
surrogate mother. 62.3 % of born animals showed to carry stable transposase-mediated 
genomic integrations of transposon DNA. All transgenic founder animals showed 
proper expression of the reporter gene Venus which could be easily detected by 
fluorescence. Germ line transmission was proved by inheritance analysis and showed 
that every founder animal had transgene carrying pups within their litters. Silencing 
events were found only in two out of nearly 300 analysed F1 animals.  
The hyperactivity of SB100X led to multiple integration events in about two third of 
founder animals. Only one third of founders carried single integrations which are 
essential for establishing a transgenic mouse model. Compared to the conventional 
production of transgenic mice via pronuclear microinjection where injected linear 
fragments often form concatemeres, transposase catalyzed insertion leads to only one 
transgene copy per integration locus. This is a great advantage, because concatemeres 
can lead to chromosomal rearrangements with fatal consequences.  
This study shows that the generation of transgenic mouse models with transposons, 
especially with the SB100X system, is possible and has several advantages compared 
to the conventional method of pronuclear injection. 
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Zusammenfassung 
 
Transgene Tiermodelle sind unverzichtbare Werkzeuge geworden um Genfunktionen 
und deren Regulationsmechanismen zu untersuchen. Besonders die Maus ist aufgrund 
ihres kurzen Lebenszyklus und der genetischen Ähnlichkeit zum Menschen ein viel 
verwendetes Modell für die Genetik und Molekurarbiologie der Säugetiere. Die 
Vorkerninjektion von rekombinanten DNA Sequenzen ist die gängige Methode um 
transgene Mäuse mit stabil vererbbaren genomischen Integrationen zu erzeugen.  
DNA Transposons wurden durch ihre zahlreichen Anwendungsmöglichkeiten in der 
Drosophila-Genetik als Werkzeuge für Mutagenesestudien bekannt. Auch für 
Manipulationen am Genom von Prokaryoten oder niederen Metazoen hat sich die 
Verwendung von Transposons als nützlich erwiesen. Kürzlich wurden die mobilen 
DNA Elemente auch für Anwendungen am Vertebratengenom bis hin zur Verwendung 
bei der Erstellung transgener Mäuse etabliert.  
Für diese Studie wurde eine hyperaktive Transposase, SB100X, verwendet um 
transgene Mäuse mit stabilen genomischen Integrationen des Reportergens Venus zu 
erzeugen. Dazu wurde ein Donor-Plasmid mit der Sequenz für Venus, welche von so 
genannten Inverted Repeats flankiert ist, gemeinsam mit der mRNA als 
Transposasequelle in den Vorkern einer murinen Zygote injiziert. Die manipulierten 
Embryonen wurden von Ammentieren ausgetragen. 62,3 % der geborenen Tiere 
zeigten Transposase-vermittelte stabile Integrationen der eingebrachten 
Transposonsequenz. Expression des Reportergens bringt ein fluoreszierendes Protein 
hervor, wodurch die Genexpression des Transgens leicht untersucht werden konnte. 
Die Genexpression von Venus konnte in allen transgenen Foundertieren nachgewiesen 
werden. Durch Verpaarung der Founder mit Wildtyptieren konnte die 
Keimbahngängigkeit der fremden Sequenzen gezeigt werden. Jedes Foundertier hatte 
unter seiner Nachkommenschaft mehr oder weniger transgene Jungtiere, wobei auch 
beinahe alle davon das Reportergen Venus exprimieren. Bei nur zwei von beinahe 300 
analysierten Tieren der F1 Generation wurde keine Venus-Expression nachgewiesen.  
Aufgrund der großen katalytischen Aktivität von SB100X trägt die Mehrheit (zwei 
Drittel) der transgenen Tiere Mehrfachintegrationen. Bei einem Drittel der 
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Foundertiere wurden Einfachintegrationen gefunden, welche essentiell für die 
Etablierung eines transgenen Tiermodells sind.  
Bei der konventionellen Vorkerninjektion werden lineare DNA Fragmente injiziert, die 
sich aneinanderlagern und so genannte Konkatemere bilden, die im Mausgenom zu 
chromosomalen Umlagerungen mit fatalen Folgen führen können. Die Verwendung 
von Transposons schließt die Konkatemerisierung aus und führt zu nur einer Kopie des 
Transgens pro Integrationsstelle.  
In dieser Studie konnte gezeigt werden, dass die Herstellung transgener Mausmodelle 
mittels Transposons, insbesondere mittels SB100X, nicht nur möglich ist, sondern auch 
diverse Vorteile im Vergleich zur herkömmlichen Vorkerninjektion mit sich bringt.  
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6.3 Curriculum Vitae 
 
 
 
Personal Data: 
 
 
Name:    Katharina Katter 
Date of Birth:    10.04.1986  
Place of Birth:   Eisenstadt, Austria 
Marital Status:   unmarried 
Nationality:    Austrian 
 
 
 
Education: 
 
 
1992-1996:  Elementary School in St. Margarethen, Burgenland 
(Austria) 
 
1996-2000:    Secondary School Theresianum Eisenstadt (Austria) 
 
2000-2004:    Upper School Theresianum Eisenstadt 
 
July 2004: School Leaving Examination (Matura) passed with 
distinction 
 
October 2004:  Entering the Diploma Study of Genetics and Microbiology 
as a branch of Biology at the University of Vienna 
 
March 2006: Finishing first part of Study in minimum time  
Receiving the first Diploma 
 Entering second part of Study with the chosen special 
field of genetic engineering and biotechnology 
 
October 2008 – July 2009: Diploma Thesis at the University for Veterinary Medicine 
Vienna, Institute for Laboratory Animal Science on 
“SB100X-mediated Mouse Transgenesis” (Supervisor: 
Prof. Dr. Thomas Rülicke) 
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Internships: 
 
 
• Practical course at the Medical Diagnostic Laboratory Dr. Böhm – Bacteriology  
in Vienna (July 2006) 
 
• Molecular biological internship at the Ludwig Boltzmann Institute for Osteology 
Vienna (September 2007) 
 
• Internship in the cancer research lab at Boehringer Ingelheim Pharma Ges. m. 
b. H. Vienna (August and September 2008) 
 
• Participation on the course “Einführung in die Labortierkunde” FELASA B 
(Introduction to the handling of laboratory animals) 
 
 
 
Additional Skills: 
 
 
• Violin Study from 1992 to 2006 at the Joseph Haydn Conservatory Eisenstadt 
 
• Several prizes won at music competitions in Austria 
 
• Played in international orchestras 
 
 
 
Command of language: 
 
 
 German as Mother Tongue 
 Fluent in English (iBT TOEFL, March 2009) 
 Basic Knowledge in Italian 
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Lebenslauf 
 
 
 
 
Persönliche Daten 
 
Name:    Katharina Katter 
Geburtsdatum bzw. -ort:  10.04.1986 in Eisenstadt 
Familienstand:   ledig 
Staatsbürgerschaft:   Österreich 
 
 
 
Schulische Ausbildung: 
 
 
1992-1996:  Volksschule in St. Margarethen, Burgenland 
 
1996-2000: Hauptschule Theresianum Eisenstadt 
 
2000-2004: Oberstufenrealgymnasium Theresianum Eisenstadt 
 
Juli 2004:  Matura mit ausgezeichnetem Erfolg 
 
Oktober 2004:  Beginn des Diplomstudiums Biologie an der Universität 
Wien 
 
Februar 2006: Abschluss des ersten Studienabschnitts in 
Mindeststudienzeit und Beginn des Studienzweigs 
Genetik und Mikrobiologie mit Spezialisierung auf Gen- 
und Biotechnologie 
 
Oktober 2008-Juli 2009: Praktische Arbeit an der Diplomarbeit mit dem Thema 
„SB100X-mediated Mouse Transgenesis“ am Institut für 
Labortierkunde, Veterinärmedizinische Universität Wien 
unter der Leitung von Prof. Dr. Thomas Rülicke 
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Außeruniversitäre Praktika 
 
• Praktikum im Medizinisch Diagnostischen Labor Dr. Böhm, Bakteriologie im 
Sommer 2006 
 
• Molekularbiologisches Praktikum im Ludwig Boltzmann Institut für Osteologie 
im Hanuschkrankenhaus Wien im September 2007 
 
• Ferialpraktikum bei Boehringer Ingelheim Pharma Ges. m. b. H. im Bereich der 
Krebsforschung im Sommer 2008 
 
• Teilnahme am Kurs „Einführung in die Labortierkunde“ FELASA B 
 
 
 
Zusätzliche Fähigkeiten: 
 
• Violinstudium von 1992 bis 2006 am Joseph Haydn Konservatorium Eisenstadt  
 
• Zahlreiche Auszeichnungen und Preise bei bundesweiten Musikwettbewerben 
 
• Erfahrungen in internationalen Orchestern 
 
 
Sprachkenntnisse: 
 
• Deutsch als Muttersprache 
• Fließendes Englisch (iBT TOEFL, März 2009) 
• Basiskenntnisse in Italienisch 
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6.4 Equipment, Chemicals, Reagents and Stocks 
 
Amersham HyperfilmTM MP 18x24 cm, GE Healthcare, Buckinghamshire, UK 
Axiovert 200, Zeiss, Vienna, A 
BioPhotometer, Eppendorf, Hamburg, D 
Cell Tram Oil, Eppendorf, Hamburg, D 
Centrifuge 5415 R, Eppendorf, Hamburg, D 
Centrifuge 5810 R, Eppendorf, Hamburg, D 
Coolpix P6000, Nikon GmbH, Vienna, A 
Ecocell, MMM Medcenter Einrichtungen GmbH, Gräfelfing, D 
Emission Filters FHS/EF-4Y2, BLS Ltd., Budapest, H 
Exitation Light Source FBL/Basic-B&N-01, BLS Ltd., Budapest, H 
FemtoJet, Eppendorf, Hamburg, D 
Gel Dryer 583, Bio-Rad, Vienna, A 
Gel iX Imager, INTAS, Göttingen, D 
GeneAmp®PCR System 9700, Applied Biosystems, Foster City, USA 
Gibco BRL Vertical Gel Electrophoresis Apparatus Model V15.17, Invitrogen, Lofer, 
A 
Goggles FHS/F-00, BLS Ltd., Budapest Hungary 
HypercassetteTM, Amersham Biosciences, Buckinghamshire, UK 
Incucell, MMM Medcenter Einrichtungen GmbH, Gräfelfing, D 
Light Head FHS/LS-1B, BLS Ltd., Budapest, H 
LSM 510 METAMK4, Zeiss, Vienna, A 
Mini-Sub Cell GT, Bio-Rad, Vienna, A 
MJ Research DNA Engine DYAD, Bio-Rad, Vienna, A 
MJ Research PTC 200 thermal cycler, Bio-Rad, Vienna, A 
OPTIMAX X-Ray Film Processor, Protec Medizintechnik GmbH & Co. KG, 
Oberstenfeld, G 
Power Supply PowerPac Basic, Bio-Rad, Vienna, A 
Power Supply PowerPac 300, Bio-Rad, Vienna, A 
Shaking Incubator 3031, GFL GmbH, Burgwedel, D 
Shandon Excelsior Tissue Processor, Thermo Fisher Scientific, Waltham, USA 
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Sub-Cell GT, Bio-Rad, Vienna, A 
Thermomixer Compact, Eppendorf, Hamburg, D 
TransferMan® NK2, Eppendorf, Hamburg, D 
Vacuum Pump, Bio-Rad, Vienna, A 
Vapor Trap, Bio-Rad, Vienna, A 
Vortex Mixer, neoLab, Heidelberg, D 
Whatman 3MM Chr, Schleicher & Schuell GmbH, Dassel, G 
 
 
Acetic acid (CH3COOH), Roth, Karlsruhe, D 
Acrylamid/Bis 19:1 (40 %), Gibco BRL, UK 
Agarose, Sigma-Aldrich, Steinheim, D 
Ampicillin, Sigma-Aldrich, Steinheim. D 
APS (Ammonium persulfate), JT Baker, Phillipsburg, USA 
Bacteriological Agar, Sigma-Aldrich, Steinheim, D 
Bacto-tryptone, Roth, Karlsruhe, D 
Borate (boric acid), Sigma-Aldrich, Steinheim, D 
Bromphenol blue, Merck, Darmstadt, D 
Chloroform isoamyl alcohol 24:1, Sigma-Aldrich, Steinheim, D 
DAPI, Molecular Probes®, Invitrogen, Lofer, A 
dNTPs, MBI Fermentas, St. Leon-Rot, D 
EDTA (Ethylene diamine tetracetic acid), Roth, Karlsruhe, D 
Ethanol absolute, Sigma-Aldrich, Seelze, D 
Ethidium bromide, Sigma-Aldrich, Steinheim, D 
Formamide, Merck, Darmstadt, D 
Glycerol, Sigma-Aldrich, Steinheim, D 
Glucose, Roth, Karlsruhe, D 
Histo-Comp, Vogel, Giessen, D 
Isopropanol, Sigma-Aldrich, Seelze, D 
LB EZ Mix, Sigma-Aldrich, Steinheim, D 
Magnesium chloride (MgCl2), Roth, Karlsruhe, D 
Magnesium sulphate (MgSO4), Roth, Karlsruhe, D 
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Mowviol 4-88, Hoechst, Frankfurt, D 
PBS, Sigma, Vienna, A 
Phenol, Sigma-Aldrich, Steinheim, D 
Potassium chloride (KCl), Roth, Karlsruhe, D 
Sodium chloride (NaCl), Roth, Karlsruhe, D 
Sodium dodecyl sulphate (SDS), JT Baker, Phillipsburg, USA 
Sucrose, Sigma-Aldrich, Steinheim, D 
TEMED (Tetramethylethylendiamin), Invitrogen, Lofer, A 
Tris, Roth, Karlsruhe, D 
Urea, Fluka, CH 
Water biochemical, Molecular Biology Grade, VWR International GmbH, Darmstadt, 
D 
Xylene, Sigma,Vienna, A 
Xylene Cyanol FF, Sigma-Aldrich, Steinheim, D 
Yeast exctract, Roth, Karlsruhe, D 
 
 
6.5 Enzymes, Kits, Oligos 
 
BioTaq DNA- Polymerase, Dialat Ltd., Moskau, RU 
Calf Intestine Alkaline Phosphatase (CIAP), Fermentas GmbH, St. Leon-Rot, D 
GeneRuler™ DNA ladder mix, Fermentas GmbH, St. Leon-Rot, D 
NucleoBond® PC100, Machery-Nagel, Düren, D 
Oligo Sequences, Fisher Scientific, Vienna, A 
Proteinase K, Fermentas GmbH, St. Leon-Rot, D 
Restriction Endonuclease FspBI (BfaI), Fermentas GmbH, St. Leon-Rot, D 
Restriction Endonuclease BglI, Fermentas GmbH, St. Leon-Rot, D 
T4 DNA Ligase, Fermentas GmbH, St. Leon-Rot, D 
T4 Polynucleotide Kinase (PNK), Fermentas GmbH, St. Leon-Rot, D 
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6.6 Software 
 
Digital Imaging KS300/KS400, Zeiss, Vienna, A 
in silico PCR http://insilico.ehu.es/PCR/ 
NCBI-BLAST (nucleotide-nucleotide, blastn) http://www.ncbi.nlm.nih.gov/blast/ 
NCBI-Pubmed http://www.ncbi.nlm.nih.gov/ 
NEBcutter, New England BioLabs V2.0 http://tools.neb.com/NEBcutter2/index.php 
(Vincze et al., 2003) 
Primer 3 version 0.4.0 http://frodo.wi.mit.edu/ 
Screenshot Gel iX and Gel Jet Imager Acquisition Software INTAS 
TierBase version 3.8.5 Nielson and Mossmann, 2003 
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6.7 Recipes for Buffers and Reagents 
 
 
50x TAE, 1 l 
 
242 g Tris base  
57.1 ml glacial acetic acid  
37.2 g Na2EDTA x 2H2O  
H2O to 1 l 
 
 
10x TBE, 1 l 
 
108 g Tris base (890 mM)  
55 g boric acid (890 mM)  
40 ml 0.5M EDTA, pH 8.0  
H2O to 1 l 
 
 
0.5 M EDTA, 1 l 
 
186.1 g Na2EDTA x 2H2O 
dissolve in 700 ml H2O 
adjust pH to 8.0 with 10 M NaOH (~50 ml) 
add H2O to 1 l 
autoclave 
 
 
TE pH 8.0, 50ml 
 
10 mM  Tris-Cl 
1 mM EDTA pH 8.0 
 
 
1 M Tris-Cl, 1 l 
 
121 g Tris base 
dissolve in 800 ml H2O 
adjust to desired pH with concentrated HCl 
mix and add H2O to 1 l 
autoclave 
 
 
 
 
 
 
 78 
10x Loading Buffer for Agarose Electrophoresis 
 
50 % glycerol 
0.1 M EDTA pH 8.0 
0.05 % Bromophenol Blue 
0.05 % Xylene Cyanol FF 
 
 
LB Medium, 1 l 
 
20.6 g LB EZ Mix  
H2O to 1 l 
autoclave 
 
 
LB Agar, 1 l 
 
20.6 g LB EZ Mix 
15 g Bacteriological Agar  
H2O to 1 l 
autoclave 
 
 
SOC-Medium 
 
2 % Bacto-tryptone  
0.5 % Yeast exctract  
10 mM NaCl 
2.5 mM KCl 
10 mM MgCl2 
10 mM MgSO4 
20 mM Glucose* 
dissolve in H2O and adjust pH to 7.0 NaOH 
autoclave 
 
*Add sterile filtered glucose after autoclaving. 
 
 
10x PCR Buffer 
 
200 mM Tris-HCl pH 8.0 
500 mM KCl 
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HOM Buffer 
 
160 mM Sucrose 
100 mM Tris-HCl pH 8.0 
80 mM EDTA pH 8.0 
0.5 % SDS 
 
 
PKII Buffer 
 
25 mM Tris-HCl pH 8.4 
37 mM KCl 
1.5 mM MgCl2 
 
 
2x Formamide Loading Buffer 10 ml 
 
9.5 ml Formamide 
0.4 ml 0.5M EDTA, pH 8.0 
2.5 mg Xylene Cyanol FF 
2.5 mg Bromphenol Blue 
 
 
 
 
